<SEC-DOCUMENT>0001140361-20-002903-index.html : 20200212
<SEC-HEADER>0001140361-20-002903.hdr.sgml : 20200212
<ACCEPTANCE-DATETIME>20200212151953
ACCESSION NUMBER:		0001140361-20-002903
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20200212
DATE AS OF CHANGE:		20200212

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRISPR Therapeutics AG
		CENTRAL INDEX KEY:			0001674416
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				473173478
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89674
		FILM NUMBER:		20603704

	BUSINESS ADDRESS:	
		STREET 1:		BAARERSTRASSE 14
		CITY:			ZUG
		STATE:			V8
		ZIP:			CH-6300
		BUSINESS PHONE:		6173154600

	MAIL ADDRESS:	
		STREET 1:		BAARERSTRASSE 14
		CITY:			ZUG
		STATE:			V8
		ZIP:			CH-6300

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nikko Asset Management Americas, Inc.
		CENTRAL INDEX KEY:			0001480751
		IRS NUMBER:				941302123
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0310

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		605 THIRD AVENUE
		STREET 2:		38TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10158
		BUSINESS PHONE:		212-610-6100

	MAIL ADDRESS:	
		STREET 1:		605 THIRD AVENUE
		STREET 2:		38TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10158
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>formsc13g.htm
<DESCRIPTION>SC 13G
<TEXT>
Document 1 - file: formsc13g.htm

</DOCUMENT>
</SEC-DOCUMENT>